Search Results 691-700 of 25892 for crohns disease

1. Another Promising Application for Stem Cells: Crohn’s Complications / Date: May 2016 Intro

   Intro: New research at Mayo Clinic is bringing hope to hundreds of thousands of Crohn's disease patients. Their extreme pain from complications is both physical ...

2. Gui Piovezani Ramos, M.D. - Doctors and Medical Staff - Mayo Clinic

   Gui Ramos is a board-certified gastroenterologist specializing in Inflammatory Bowel Diseases (IBD). Dr. Ramos is dedicated to managing complex cases of Crohn's ...

3. A Study to Evaluate the Long-Term Effectiveness, Safety, and Tolerability of Repeated Administration of ABT-494 in Patients with Crohn's Disease - Mayo Clinic

   ... and Tolerability of Repeated Administration of ABT-494 in Patients with Crohn's Disease ... and stage of disease, and previous treatments or health concerns.

4. Inflammatory bowel disease (IBD) · Ischemic colitis (colon inflammation caused by reduced blood flow); Proctitis (inflammation of the lining of the rectum) ...

5. Jami A. Kinnucan, M.D. - Doctors and Medical Staff - Mayo Clinic

   Kinnucan has expertise in the evaluation and management of patients with inflammatory bowel disease (IBD) including ulcerative colitis and Crohn's disease, as ...

6. Gastroesophageal reflux disease (GERD) - Doctors and departments - Mayo Clinic

   ... Crohn's disease, Colon polyps, Rectal prolapse ... olypectomy, Gastroesophageal reflux disease, Diarrhea, Celiac disease ... Mayo Clinic research scientists and ...

7. A Study To Evaluate The Effectiveness, Safety And Movement Of Ustekinumab In Pediatric Patients With Moderate-to-Severe, Active Crohn's Disease - Mayo Clinic

   A Study To Evaluate The Effectiveness, Safety And Movement Of Ustekinumab In Pediatric Patients With Moderate-to-Severe, Active Crohn's Disease. Print details.

8. A Study to Evaluate the Safety and Effectiveness of Risankizumab in Subjects with Moderately to Severely Active Crohn's Disease - Mayo Clinic

   A Study to Evaluate the Safety and Effectiveness of Risankizumab in Subjects with Moderately to Severely Active Crohn's Disease ... and stage of disease, and ...

9. Minnesota - Mayo Clinic News Network

   ... inflammatory bowel disease (IBD), including Crohn's[...] Mayo Clinic announces upcoming leadership transition, recognizes transformational leadership of Dr ...

10. Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission - Mayo Clinic

    ... inflammatory bowel disease (IBD) (Crohn's ... Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns.